The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States
- 10 April 2024
- journal article
- research article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 64 (4) , 102093
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse
This publication has 29 references indexed in Scilit:
- Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012–2019American Journal of Preventive Medicine, 2021
- State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmaciesDrug and Alcohol Dependence, 2021
- Implications of county-level variation in U.S. opioid distributionDrug and Alcohol Dependence, 2021
- Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in AccessAmerican Journal of Preventive Medicine, 2020
- Availability of Naloxone at Rural Georgia Pharmacies, 2019JAMA Network Open, 2020
- Assessment of Pharmacy Closures in the United States From 2009 Through 2015JAMA Internal Medicine, 2020
- Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid OverdoseJournal of General Internal Medicine, 2019
- Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal OverdoseJAMA Internal Medicine, 2019
- State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmaciesDrug and Alcohol Dependence, 2018
- Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United StatesDrug and Alcohol Dependence, 2018